Ultrasound Treatment for Huntington's Disease Movement Symptoms
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This trial tests a new focused ultrasound technique aimed at reducing involuntary movements (chorea) in people with Huntington's disease. The treatment targets a specific brain region and may help improve movement control and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have been genetically confirmed to have Huntington's disease with a CAG repeat of 40 or higher
- You have moderate to severe involuntary movements (chorea) that impact daily function
- You have a reliable family member or caregiver who can support you during the trial
- You do not have severe memory or thinking problems that would make it hard to report side effects
- You have no metallic implants (like pacemakers or cochlear implants) in your body
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a gentle magnetic device placed on the head (transcranial static magnetic stimulation) can reduce chorea (involuntary movements) in people with Huntington's disease. You'll keep your usual medications during the study.
This study tests whether a gentle brain stimulation device (tDCS) used at home can help improve thinking and behavior in people with Huntington's disease. A caregiver is needed to be present during treatment and help with questionnaires.
This trial tests an at-home, noninvasive brain stimulation treatment to help with behavioral and cognitive (thinking) symptoms in people with Huntington’s disease. You and a caregiver work together during sessions and questionnaires to see if symptoms improve and stay stable.
This study uses low-intensity focused ultrasound to stimulate a deep brain area and reduce hand tremors. It is for people with Parkinson's disease, essential tremor, or dystonic tremor whose medications don't work well enough.
This trial tests a gentle ultrasound treatment (LIFUS) for people with various brain conditions like epilepsy, tumours, or movement disorders. It aims to see if this non-invasive approach can help where other treatments are being used.
This study tests whether low-intensity focused ultrasound can improve both motor and non-motor symptoms of essential tremor. It is for people whose tremor is not well-controlled with medication and who are willing to undergo MRI and study visits.
Hear when a new Huntington Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.